JUBLINGREA Share Price Performance
₹0
-669.60 (-100.00%)
Price ₹0
Fair Value₹1,250.00
Share Pricen/a
Jubilant Ingrevia (NSE:JUBLINGREA) Shareholders Will Want The ROCE Trajectory To Continue
Nov 07
Jubilant Ingrevia Limited Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 5 Fair Values set on narratives written by author
JUBLINGREA Community Narratives
AN
Fair Value ₹1.25k 42.4% undervalued intrinsic discount
Rising Green Chemistry Demand Will Reimagine Global Specialty Markets
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
Fair Value ₹987.75 27.1% undervalued intrinsic discount
Improved Margins And Board Meeting Will Shape Export Opportunity Outlook
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
Fair Value ₹743 3.1% undervalued intrinsic discount
Regulatory Tensions And China+1 Shifts Will Test Recovery Prospects
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Improved Margins And Board Meeting Will Shape Export Opportunity Outlook
Key Takeaways Expansion in specialty chemicals and nutrition, combined with new export opportunities and supply chain shifts, is fueling sustained growth and higher-margin revenues. Strategic investments, cost optimization, and backward integration are strengthening profitability and supporting the company's shift toward more resilient, value-added business segments.Read more
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
₹987.75
27.1% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
15.82% p.a.
Profit Margin
9.39%
Future PE
36.49x
Share price in 2028
₹1.45k
Rising Green Chemistry Demand Will Reimagine Global Specialty Markets
Key Takeaways Rapid capacity expansion, strong product pipeline, and backward integration will drive sustained revenue growth, boosted margins, and long-term market leadership across key segments. Strategic focus on innovation, sustainable practices, and premium export markets positions the company for resilient, high-quality earnings amid global supply chain shifts.Read more
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
₹1.25k
42.4% undervalued intrinsic discount
AnalystHighTarget Fair Value
Revenue growth
21.49% p.a.
Profit Margin
11.01%
Future PE
34.87x
Share price in 2028
₹1.83k
Regulatory Tensions And China+1 Shifts Will Test Recovery Prospects
Key Takeaways Strengthening demand and export growth are offset by regulatory, supply chain, and technological risks that could threaten profitability and long-term revenue sustainability. Heavy capital requirements and product concentration heighten earnings volatility and may constrain the company's ability to capture future industry upswings.Read more
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
₹743
3.1% undervalued intrinsic discount
AnalystLowTarget Fair Value
Revenue growth
18.6% p.a.
Profit Margin
8.57%
Future PE
28.58x
Share price in 2028
₹1.08k
Recently Updated Narratives
AN
Improved Margins And Board Meeting Will Shape Export Opportunity Outlook
Fair Value: ₹987.75 27.1% undervalued intrinsic discount
2 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Regulatory Tensions And China+1 Shifts Will Test Recovery Prospects
Fair Value: ₹743 3.1% undervalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Rising Green Chemistry Demand Will Reimagine Global Specialty Markets
Fair Value: ₹1.25k 42.4% undervalued intrinsic discount
1 followerusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Jubilant Ingrevia Limited Key Details
About JUBLINGREA
- Founded
- 2019
- Employees
- 2139
- CEO
- WebsiteView website
Jubilant Ingrevia Limited engages in life science products and solutions in India, the United States, Europe, China and internationally. The company operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Chemical Intermediates. The Specialty Chemicals segment offers bio-pyridine and -picolines, fine chemicals, agro chemicals, custom development and manufacturing services, and microbial control solutions. The Nutrition & Health Solutions segment provides nutrition and health ingredients; and animal and human nutrition health solutions. The Chemical intermediates segment offers acetyls and specialty ethanol. In addition, it provides vitamins, mineral premixes, stress regulator, amino acid, herbal choline, herbal non-antibiotic growth promoter and egg quality enhancer, toxin binder, acidifiers, and enzymes and emulsifiers. The company serves pharmaceutical, nutrition, agrochemical, consumer, and industrial sectors. The company was formerly known as Jubilant LSI Limited and changed its name to Jubilant Ingrevia Limited in October 2020. Jubilant Ingrevia Limited was incorporated in 2019 and is headquartered in Noida, India.
